The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

The precision screening intervention will consist of an interpreted prostate cancer genetic risk assessment (GRA) report, provided to the participant along with tailored prostate cancer screening recommendations and, in cases of high genetic risk, genetic counseling. The risk report and supporting educational materials will also be provided to the participant's primary care provider. Usual care in this study includes receipt of a brief brochure about shared decision-making in prostate cancer screening.

Usual care in this study includes receipt of a brief brochure about shared decision-making in prostate cancer screening.